Buprenorphine, a relative newcomer in the treatment of opioid addiction, is growing in popularity among California doctors as regulatory changes, physician training and other initiatives make the medication more widely accessible.
May 29, 2019
0
1
The opioid epidemic may have cost U.S. state and federal governments up to $37.8 billion in lost tax revenue due to opioid-related employment loss, according to Penn State researchers.
Apr 11, 2019
0
6
Despite federal and state efforts to reduce opioid availability and increase treatment access, opioid-related deaths are on the rise in New York and 29 other states. To examine whether geographic access to treatment options ...
Mar 29, 2019
0
4
Orthopedic surgeons at Hospital for Special Surgery (HSS) in New York City have developed a pain management pathway designed to reduce the use of opioid analgesics after joint procedures. The effort is part of the hospital's ...
Mar 12, 2019
0
0
There is a breadth of academic research demonstrating that there are three medications that successfully treat opioid use disorder (OUD): methadone, buprenorphine, and naltrexone. However, patients face unnecessary barriers ...
Dec 18, 2018
0
0
(HealthDay)—While opioid agonist pharmacotherapy continues to be the recommended therapy for pregnant women with an opioid use disorder, medically supervised withdrawal can be considered under the care of a physician experienced ...
Jul 28, 2017
0
1
Recent years have seen a change in drug use patterns, especially for older adults, with an increase in their admission to substance abuse treatment and increased injection drug use among those over the age of 50. Yet, there ...
Nov 23, 2015
0
126
A survey of opioid treatment programs finds that the proportion offering on-site testing for human immunodeficiency virus (HIV) and sexually transmitted infections (STIs) declined substantially between 2000 and 2011, despite ...
Dec 24, 2013
0
0
